Výsledky vyhledávání - "Edouard Lebacq"

Comparative Tolerability and Immunogenicity of Typherix??? or Typhim Vi??? in Healthy Adults*

Autor: Edouard Lebacq

Publikováno v: BioDrugs. 15:5-12

This study was carried out to compare the immunogenicity and tolerability of Typherix, a recently developed typhoid Vi polysaccharide vaccine, with Typhim Vi, the first available Vi polysaccharide vaccine, in healthy adults. Three different productio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62faf6ccb0512acd9e11ed37648fe8ef
https://doi.org/10.2165/00063030-200115001-00002

Zobrazit plný text záznamu

Concomitant Vaccination against Hepatitis A and Typhoid Fever

Autor: Edouard Lebacq, Jiri Beran, Françoise Collard, Roman Prymula, Christian Van Hoecke

Publikováno v: Journal of Travel Medicine. 5:116-120

Backgrground: The purpose of this study was to evaluate the reactogenicity and immunogenicity of a hepatitis A vaccine (Havrix-1440TM) when administered simultaneously with a Vi polysaccharide typhoid vaccine. Methods: Two open, randomized studies we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b20129e0dfed139f5f11bda3a5ad9c67
https://doi.org/10.1111/j.1708-8305.1998.tb00483.x

Zobrazit plný text záznamu

Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years

Autor: Gudrun Maechler, Dominique Boutriau, Edouard Lebacq, Lars Østergaard, Jan Poolman

Publikováno v: Østergaard, L J, Lebacq, E, Poolman, J, Maechler, G & Boutriau, D 2008, ' Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years ', Vaccine, vol. 27, no. 1, pp. 161-8 . https://doi.org/10.1016/j.vaccine.2008.08.075

Udgivelsesdato: 2009-Jan-1 Development of meningococcal serogroups A, C, W-135 and Y conjugate vaccines could expand coverage against devastating meningococcal diseases. The immunogenicity of one dose of each one of five MenACWY-TT formulations versu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e510370a357fabfd274e9d97d6438753
https://pubmed.ncbi.nlm.nih.gov/18834910

Zobrazit plný text záznamu

Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab)

Autor: Daniela Acerbi, Fabrice Nollevaux, Edouard Lebacq, Gianluigi Poli, Bernard Jeanbaptiste, Xavier Deroubaix, Steven De Bruyn, Armel Stockis

Publikováno v: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 53(1)

The influences of food, tablet splitting, and fractional dosing on the pharmacokinetics of a new controlled-release double-scored tablet containing 60 mg isosorbide-5-mononitrate (Monoket Multitab) were investigated in healthy male volunteers. Food i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b88b34685a04024ef1411d56c0d28a0
https://pubmed.ncbi.nlm.nih.gov/11777752

Zobrazit plný text záznamu

Corrigendum to 'Immunogenicity, reactogenicity and persistence of meningococcal A, C,W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years' [Vaccine 27 (2009) 161–168]

Autor: Lars Østergaard, Edouard Lebacq, Gudrun Maechler, Jan Poolman, Dominique Boutriau

Publikováno v: Vaccine. 27:7467

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eee3d4390a50480953425e014853c58d
https://doi.org/10.1016/j.vaccine.2009.09.037

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání